Judge Tim Fox fined Johnson & Johnson and its subsidiary Janssen $1.1 billion today for nearly 240,000 violations of Arkansas’ Medicaid fraud law. Yesterday a jury found that the companies had hidden the risks of taking Risperdal. J&J will pay an additional $11 million for 4,500 violations of Arkansas’ deceptive practices act. The jury awarded its verdict after three hours of deliberation; Janssen indicated it will move for a new trial, and appeal if necessary.
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.